Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.

The Johns Hopkins University spinout’s latest funding will go toward further developing its lead candidate, VTA-110, for muscular dystrophy treatments.

Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.

UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

Today's deal net contains news from Boston Metal, Evologic Therapeutics, Lilz, GaitQ, Hemerion Therapeutics and Rebrain.

Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.